 |
인쇄하기
취소
|
Yungjin offers apology for Coenzyme Q10 patent infringement
Yungjin Pharm admitted that it has violated Coenzyme Q10-related patent Daewoong Chemical and Daewoong Pharm has owned and carried its apology in trade papers.
Last year, Daewoong filed a suit against Yungjin over alleged patent infringement of its Coenzyme Qn intermediates.
Yungjin completed its CoQ10 production plant with a production volume of 50 tons last year to meet the world's dema...
Last year, Daewoong filed a suit against Yungjin over alleged patent infringement of its Coenzyme Qn intermediates.
Yungjin completed its CoQ10 production plant with a production volume of 50 tons last year to meet the world's dema...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.